Dietrich-Muszalska A and Olas B |
Isoprostenes as indicators of oxidative stress in schizophrenia. |
2009 |
World J. Biol. Psychiatry |
pmid:19673085
|
Hall JA et al. |
Dietary fish oil alters the lysophospholipid metabolomic profile and decreases urinary 11-dehydro thromboxane Bâ‚‚ concentration in healthy Beagles. |
2011 |
Vet. Immunol. Immunopathol. |
pmid:21925741
|
Mullins KB et al. |
Effects of carprofen, meloxicam and deracoxib on platelet function in dogs. |
2012 |
Vet Anaesth Analg |
pmid:22248445
|
Smith SR et al. |
Chronic thromboxane synthase inhibition with CGS 12970 in human cyclosporine nephrotoxicity. |
1993 |
Transplantation |
pmid:8279014
|
Takasaki W et al. |
Superiority of plasma 11-dehydro-TXB2 to TXB2 as an index of in vivo TX formation in rabbits after dosing of CS-518, a TX synthase inhibitor. |
1993 |
Thromb. Res. |
pmid:8367836
|
Carroll RC et al. |
Post interventional cardiology urinary thromboxane correlates with PlateletMapping detected aspirin resistance. |
2010 |
Thromb. Res. |
pmid:19962724
|
Kawamura M et al. |
Evaluation of plasma 11-dehydro-thromboxane B2 as an indicator for thromboxane A2 synthesis in vivo in laboratory animals. |
1995 |
Thromb. Res. |
pmid:7778061
|
Cholette JM et al. |
Aspirin resistance following pediatric cardiac surgery. |
2010 |
Thromb. Res. |
pmid:20550971
|
Perneby C et al. |
Prothrombotic responses to exercise are little influenced by clopidogrel treatment. |
2004 |
Thromb. Res. |
pmid:15381386
|
Chakroun T et al. |
Screening for aspirin resistance in stable coronary artery patients by three different tests. |
2007 |
Thromb. Res. |
pmid:17553552
|
Kudolo GB et al. |
Effect of the ingestion of Ginkgo biloba extract on platelet aggregation and urinary prostanoid excretion in healthy and Type 2 diabetic subjects. |
2002 |
Thromb. Res. |
pmid:12590952
|
Di Minno MN et al. |
Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis. |
2011 |
Thromb. Res. |
pmid:21669453
|
Saloheimo P et al. |
Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage. |
2005 |
Thromb. Res. |
pmid:15733969
|
Pirich C et al. |
Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients. |
1999 |
Thromb. Res. |
pmid:10588465
|
Perneby C et al. |
Optimization of an enzyme immunoassay for 11-dehydro-thromboxane B(2) in urine: comparison with GC-MS. |
1999 |
Thromb. Res. |
pmid:10632465
|
Antonino MJ et al. |
Antiplatelet effects of aspirin with phytosterols: comparison with non-enteric coated aspirin alone. |
2010 |
Thromb. Res. |
pmid:19446864
|
Santilli F et al. |
Effects of high-amount-high-intensity exercise on in vivo platelet activation: modulation by lipid peroxidation and AGE/RAGE axis. |
2013 |
Thromb. Haemost. |
pmid:24030807
|
Spectre G et al. |
Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complications. |
2011 |
Thromb. Haemost. |
pmid:21800009
|
Davì G et al. |
Increased thromboxane metabolites excretion in liver cirrhosis. |
1998 |
Thromb. Haemost. |
pmid:9569186
|
Dragani A et al. |
Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism. |
2012 |
Thromb. Haemost. |
pmid:22782530
|
Lessiani G et al. |
Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost. |
2011 |
Thromb. Haemost. |
pmid:21103664
|
Wang JS et al. |
Effect of strenuous arm exercise on oxidized-LDL-potentiated platelet activation in individuals with spinal cord injury. |
2000 |
Thromb. Haemost. |
pmid:10928481
|
Halawani SH et al. |
Aspirin failure in patients presenting with acute cerebrovascular ischaemia. |
2011 |
Thromb. Haemost. |
pmid:21544317
|
Fruzzetti F et al. |
Platelet-vessel wall interactions with third-generation oral contraceptives: no evidence of detrimental effects. |
1999 |
Thromb. Haemost. |
pmid:10494782
|
Pettinella C et al. |
Cyclooxygenase-1 haplotype C50T/A-842G does not affect platelet response to aspirin. |
2009 |
Thromb. Haemost. |
pmid:19350112
|
Véricel E et al. |
Moderate oral supplementation with docosahexaenoic acid improves platelet function and oxidative stress in type 2 diabetic patients. |
2015 |
Thromb. Haemost. |
pmid:25832443
|
Blais N et al. |
Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). |
2009 |
Thromb. Haemost. |
pmid:19652893
|
Forastiero R et al. |
Anti-beta2 glycoprotein I antibodies and platelet activation in patients with antiphospholipid antibodies: association with increased excretion of platelet-derived thromboxane urinary metabolites. |
1998 |
Thromb. Haemost. |
pmid:9459320
|
Koudstaal PJ et al. |
Increased thromboxane biosynthesis in patients with acute cerebral ischemia. |
1993 |
Stroke |
pmid:8421822
|
Tohgi H et al. |
Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin. |
1992 |
Stroke |
pmid:1412574
|
Bruno A et al. |
Aspirin and urinary 11-dehydrothromboxane B(2) in African American stroke patients. |
2002 |
Stroke |
pmid:11779889
|
Bruno A et al. |
Serial urinary 11-dehydrothromboxane B2, aspirin dose, and vascular events in blacks after recent cerebral infarction. |
2004 |
Stroke |
pmid:14963281
|
van Kooten F et al. |
Increased platelet activation in the chronic phase after cerebral ischemia and intracerebral hemorrhage. |
1999 |
Stroke |
pmid:10066850
|
van Kooten F et al. |
Evidence for episodic platelet activation in acute ischemic stroke. |
1994 |
Stroke |
pmid:8303731
|
van Kooten F et al. |
Platelet activation and lipid peroxidation in patients with acute ischemic stroke. |
1997 |
Stroke |
pmid:9259748
|
van Kooten F et al. |
Increased thromboxane biosynthesis is associated with poststroke dementia. |
1999 |
Stroke |
pmid:10436098
|
Gonzalez-Conejero R et al. |
Biological assessment of aspirin efficacy on healthy individuals: heterogeneous response or aspirin failure? |
2005 |
Stroke |
pmid:15604423
|
Simeoni S et al. |
Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects. |
2011 |
Stress |
pmid:21434833
|
Haubelt H et al. |
Can platelet function tests predict the clinical efficacy of aspirin? |
2005 |
Semin. Thromb. Hemost. |
pmid:16149017
|
Bruce EC et al. |
Platelet thromboxane A2 secretion in patients with major depression responsive to electroconvulsive therapy. |
2008 |
Psychosom Med |
pmid:18378867
|
Suzuki N et al. |
Quantitative liquid chromatography-tandem mass spectrometric analysis of 11-dehydro TXB2 in urine. |
2004 |
Prostaglandins Other Lipid Mediat. |
pmid:15165035
|
Mizugaki M et al. |
Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method. |
1999 |
Prostaglandins Other Lipid Mediat. |
pmid:10593167
|
Hishinuma T et al. |
Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic. |
1999 |
Prostaglandins Other Lipid Mediat. |
pmid:10593168
|
Lynch CM et al. |
The role of thromboxane A(2) in the pathogenesis of intrauterine growth restriction associated with maternal smoking in pregnancy. |
2011 |
Prostaglandins Other Lipid Mediat. |
pmid:21723954
|
Nishimaki S and Seki K |
An imbalance between prostacyclin and thromboxane in relation to cerebral blood flow in neonates with maternal preeclampsia. |
1999 |
Prostaglandins Other Lipid Mediat. |
pmid:10482286
|
Suzuki N et al. |
Difference in urinary LTE4 and 11-dehydro-TXB2 excretion in asthmatic patients. |
2000 |
Prostaglandins Other Lipid Mediat. |
pmid:11060902
|
Wolfram R et al. |
Daily prickly pear consumption improves platelet function. |
2003 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12878452
|
Hishinuma T et al. |
Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. |
2001 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:11728171
|
Sinzinger H |
Comments on "Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications". |
2002 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12445490
|
Nakamura H et al. |
Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis. |
2001 Nov-Dec |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:11993724
|
Sciulli MG et al. |
Platelet activation in patients with colorectal cancer. |
2005 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:15626589
|
Tsuruta LR et al. |
Characterization of 11-dehydro-thromboxane B2 recombinant antibody obtained by phage display technology. |
2003 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12628223
|
Lorenz R et al. |
A new method using simple solid phase extraction for the rapid gas-chromatographic mass-spectrometric determination of 11-dehydro-thromboxane B2 in urine. |
1989 |
Prostaglandins |
pmid:2772221
|
Yamanaka S et al. |
11-Dehydro thromboxane B2: a reliable parameter of thromboxane A2 production in dogs. |
1993 |
Prostaglandins |
pmid:8484010
|
Schaefer WR et al. |
Urinary excretion of 2,3-dinor-6-keto-PGF1 alpha and 11-dehydro-TXB2 by the gravid spontaneously hypertensive rat. |
1996 |
Prostaglandins |
pmid:8875634
|
Westlund P et al. |
Identification of 11-dehydro-TXB2 as a suitable parameter for monitoring thromboxane production in the human. |
1986 |
Prostaglandins |
pmid:3755250
|
Kumlin M and Granström E |
Radioimmunoassay for 11-dehydro-TXB2: a method for monitoring thromboxane production in vivo. |
1986 |
Prostaglandins |
pmid:3823488
|
Chiabrando C et al. |
Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man. |
1993 |
Prostaglandins |
pmid:8321910
|
Seyberth HW et al. |
Excretion of primary prostanoids and their metabolites during acute volume expansion. |
1988 |
Prostaglandins |
pmid:3163156
|
Farker K et al. |
Measurements of urinary prostaglandins in young ovulatory women during the menstrual cycle and in postmenopausal women. |
1997 |
Prostaglandins |
pmid:9373880
|
Westlund P et al. |
Circulating and urinary thromboxane B2 metabolites in the rabbit: 11-dehydro-thromboxane B2 as parameter of thromboxane production. |
1986 |
Prostaglandins |
pmid:3520685
|
Chiabrando C et al. |
Urinary excretion of 2,3-dinor-thromboxane B1, a major metabolite of thromboxane B2 in the rat. |
1994 |
Prostaglandins |
pmid:7938613
|
d'Emmanuele di Villa Bianca R et al. |
Hydrogen sulphide pathway contributes to the enhanced human platelet aggregation in hyperhomocysteinemia. |
2013 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:24019484
|
McAdam BF et al. |
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2. |
1999 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:9874808
|
Catella F et al. |
11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation. |
1986 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:3461463
|
Montine TJ et al. |
Elevated ratio of urinary metabolites of thromboxane and prostacyclin is associated with adverse cardiovascular events in ADAPT. |
2010 |
PLoS ONE |
pmid:20174466
|
Gremmel T et al. |
Comparison of methods to evaluate aspirin-mediated platelet inhibition after percutaneous intervention with stent implantation. |
2011 |
Platelets |
pmid:21231857
|
Frisbee JC et al. |
Aspirin resistance with genetic dyslipidemia: contribution of vascular thromboxane generation. |
2010 |
Physiol. Genomics |
pmid:20530721
|
Hart RG et al. |
Aspirin dosage and thromboxane synthesis in patients with vascular disease. |
2003 |
Pharmacotherapy |
pmid:12741431
|
Saareks V et al. |
Opposite effects of nicotinic acid and pyridoxine on systemic prostacyclin, thromboxane and leukotriene production in man. |
2002 |
Pharmacol. Toxicol. |
pmid:12403056
|
Patrignani P et al. |
Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study. |
2008 |
Pharmacogenet. Genomics |
pmid:18551041
|
Heistein LC et al. |
Aspirin resistance in children with heart disease at risk for thromboembolism: prevalence and possible mechanisms. |
2008 |
Pediatr Cardiol |
pmid:17896127
|
DeFilippis AP et al. |
Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activity. |
2014 |
Nutr Metab Cardiovasc Dis |
pmid:24370448
|
Mizugaki M |
[Microdetermination of eicosanoids using mass spectrometry]. |
2000 |
Nippon Yakurigaku Zasshi |
pmid:10876809
|
Frost-Pineda K et al. |
Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. |
2011 |
Nicotine Tob. Res. |
pmid:21330277
|
McConnell JP et al. |
Urinary 11-dehydro-thromboxane B(2) and coagulation activation markers measured within 24 h of human acute ischemic stroke. |
2001 |
Neurosci. Lett. |
pmid:11684346
|
Ciabattoni G et al. |
Determinants of platelet activation in Alzheimer's disease. |
2007 |
Neurobiol. Aging |
pmid:16442186
|
Davì G et al. |
Thromboxane biosynthesis and platelet function in type II diabetes mellitus. |
1990 |
N. Engl. J. Med. |
pmid:2345567
|
Fitzgerald DJ et al. |
Platelet activation in unstable coronary disease. |
1986 |
N. Engl. J. Med. |
pmid:3531859
|
Alessandrini P et al. |
Thromboxane biosynthesis and platelet function in type I diabetes mellitus. |
1988 |
N. Engl. J. Med. |
pmid:3292913
|
Christman BW et al. |
An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. |
1992 |
N. Engl. J. Med. |
pmid:1603138
|
Geske FJ et al. |
AspirinWorks: a new immunologic diagnostic test for monitoring aspirin effect. |
2008 |
Mol Diagn Ther |
pmid:18288882
|
Ciabattoni G et al. |
Radioimmunoassay of 11-dehydrothromboxane B2. |
1990 |
Meth. Enzymol. |
pmid:2233352
|
Fitzgerald DJ et al. |
Thromboxane A2 synthesis in pregnancy-induced hypertension. |
1990 |
Lancet |
pmid:1969511
|
|
Urinary thromboxane metabolites in pre-eclampsia. |
1990 |
Lancet |
pmid:1971907
|
Van Geet C et al. |
Possible platelet contribution to pathogenesis of transient neonatal hyperammonaemia syndrome. |
1991 |
Lancet |
pmid:1670726
|
Malini PL et al. |
Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. |
1997 |
Lancet |
pmid:9217714
|
Tönshoff B et al. |
Increased thromboxane biosynthesis in childhood hemolytic uremic syndrome. |
1990 |
Kidney Int. |
pmid:2111418
|
Kapłon-Cieślicka A et al. |
Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes. |
2013 |
Kardiol Pol |
pmid:24065375
|
Davì G et al. |
Platelet activation in obese women: role of inflammation and oxidant stress. |
2002 Oct 23-30 |
JAMA |
pmid:12387653
|
Mills JL et al. |
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study. |
1999 |
JAMA |
pmid:10432033
|
Fritsma GA et al. |
Monitoring the antiplatelet action of aspirin. |
2001 |
JAAPA |
pmid:11523339
|
Thomason J et al. |
Platelet cyclooxygenase expression in normal dogs. |
2011 Sep-Oct |
J. Vet. Intern. Med. |
pmid:21985141
|
Dudley A et al. |
Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin. |
2013 Jan-Feb |
J. Vet. Intern. Med. |
pmid:23278865
|
Lin JS et al. |
The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence. |
1992 |
J. Urol. |
pmid:1635125
|
Hartanto MD et al. |
Urinary 11-dehydro-thromboxane Bâ‚‚ and 2,3-dinor-6-keto-prostaglandin-Fâ‚α in healthy post-menopausal and pre-menopausal women receiving aspirin 100 mg. |
2012 |
J. Thromb. Thrombolysis |
pmid:22311294
|
Addad F et al. |
Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery disease. |
2010 |
J. Thromb. Thrombolysis |
pmid:19381450
|
Li C et al. |
Reversal of the anti-platelet effects of aspirin and clopidogrel. |
2012 |
J. Thromb. Haemost. |
pmid:22268852
|
Lemkes BA et al. |
The influence of aspirin dose and glycemic control on platelet inhibition in patients with type 2 diabetes mellitus. |
2012 |
J. Thromb. Haemost. |
pmid:22252020
|
Santilli F et al. |
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus. |
2010 |
J. Thromb. Haemost. |
pmid:20088941
|